Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LucidMood is a consumer wellness brand originally known for cannabis vape and related THC/CBD products formulated with terpene and botanical blends to deliver specific mood-oriented effects. The company was founded in 2015 and built an early reputation in the U.S. cannabis market as a terpene-focused brand with named product experiences such as Luminous, Loving, Lively, Luscious, and Lullaby. LucidMood was acquired by Palmer Jane in January 2022 for an undisclosed price. More recently, the LucidMood brand has appeared online as a wellness products business marketing functional mushroom gummies aimed at daytime energy/focus and nighttime calm/recovery. It is not a biotech or pharmaceutical drug developer and does not appear to have a clinical-stage therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LucidMood.